Zine News

Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019

Loughborough, England, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today reported financial results for the first quarter ended June 30, 2019.


Publicaciones relacionadas

Botón volver arriba